Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16,525 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Inhibition of bone erosion, determined by high-resolution peripheral quantitative computed tomography (HR-pQCT), in rheumatoid arthritis patients receiving a conventional synthetic disease-modifying anti-rheumatic drug (csDMARD) plus denosumab vs csDMARD therapy alone: an open-label, randomized, parallel-group study.
Iwamoto N, Chiba K, Sato S, Shiraishi K, Watanabe K, Oki N, Okada A, Koga T, Kawashiri SY, Tamai M, Hosogaya N, Furuyama M, Kobayashi M, Saito K, Okubo N, Uetani M, Osaki M, Kawakami A. Iwamoto N, et al. Among authors: watanabe k. Arthritis Res Ther. 2022 Dec 7;24(1):264. doi: 10.1186/s13075-022-02957-w. Arthritis Res Ther. 2022. PMID: 36476479 Free PMC article. Clinical Trial.
Association of denosumab with serum cytokines, chemokines, and bone-related factors in patients with rheumatoid arthritis: A post hoc analysis of a multicentre, open-label, randomised, parallel-group study.
Iwamoto N, Sato S, Furukawa K, Michitsuji T, Shiraishi K, Watanabe K, Chiba K, Osaki M, Kawakami A. Iwamoto N, et al. Among authors: watanabe k. Mod Rheumatol. 2024 Aug 20;34(5):936-946. doi: 10.1093/mr/roae002. Mod Rheumatol. 2024. PMID: 38226481 Clinical Trial.
Effects of daily teriparatide, weekly high-dose teriparatide, or bisphosphonate on cortical and trabecular bone of vertebra and proximal femur in postmenopausal women with fragility fracture: Sub-analysis by quantitative computed tomography from the TERABIT study.
Takahashi R, Chiba K, Okazaki N, Era M, Yokota K, Yabe Y, Kondo C, Fukuda T, Fukushima K, Kono M, Michikoshi Y, Yamada S, Iida T, Mitsumizo K, Sato S, Doi M, Watanabe K, Ota S, Shiraishi K, Yonekura A, Osaki M. Takahashi R, et al. Among authors: watanabe k. Bone. 2024 Oct;187:117189. doi: 10.1016/j.bone.2024.117189. Epub 2024 Jul 2. Bone. 2024. PMID: 38960296 Free article. Clinical Trial.
Aromatase inhibitors, bone microstructure, and estimated bone strength in postmenopausal women with breast cancer: a 5-year prospective study.
Kuba S, Chiba K, Watanabe K, Matsumoto M, Morita M, Akashi M, Yukutake A, Hara Y, Fukushima A, Inamasu E, Otsubo R, Yamanouchi K, Kanetaka K, Osaki M, Matsumoto K, Eguchi S. Kuba S, et al. Among authors: watanabe k. J Bone Miner Metab. 2024 Nov 7. doi: 10.1007/s00774-024-01560-0. Online ahead of print. J Bone Miner Metab. 2024. PMID: 39508861
Electrically Switching Ferroelectric Order in 3R-MoS2 Layers.
Ouyang T, Cha S, Sun Y, Taniguchi T, Watanabe K, Gabor NM, Lui CH. Ouyang T, et al. Among authors: watanabe k. Nano Lett. 2025 Jan 14. doi: 10.1021/acs.nanolett.4c05370. Online ahead of print. Nano Lett. 2025. PMID: 39807830
16,525 results
You have reached the last available page of results. Please see the User Guide for more information.